No Detail Found!

Evaluation of Deep Vein Thrombosis Diagnostic and Management Approach

Author(s)
Awadh Mohammed Al-Antar Faculty of Medicine, King Khalid University,Abha, KSA,
Hassan Mohammed Asiri Faculty of Medicine, King Khalid University,Abha, KSA,
Naif Ali Alamri Faculty of Medicine, King Abdulaziz University,Jeddah, KSA,
Yazed Mustafa Alayesh Faculty of Medicine, Jeddah University,Jeddah, KSA,
Abdulmalik Khalid Alsulaimani Faculty of Medicine, Umm Al Qura University, Makkah, KSA
Samar Oweid Alshammari Faculty of Medicine, Al Jouf University,Sakaka, KSA,
Ali Salah Almohammedsaleh Department of Internal Medicine, Hail General Hospital, Hail, KSA
Zuhair Tariq Al Sulaiman Faculty of Medicine, King Faisal University,Al Ahsa, KSA,
Abdullah Abdulrahman Alatig Department of Internal Medicine, East Jeddah General Hospital, Jeddah, KSA
Ibrahim Fayiq Khayyat Faculty of Medicine, Ibn Sina National College of Medicine,Jeddah, KSA,
Renad Sultan AlOtaibi Faculty of Medicine, Ibn Sina National College of Medicine,Jeddah, KSA,
Abstract
Introduction: Deep Vein Thrombosis (DVT) is a common disease and is a subset of venous thromboembolism (VTE). It is a significant preventable cause of mortality and morbidity in the world. Anticoagulant therapeutic approaches such as heparin and also vitamin K antagonists were introduced during the early 20th century. The development of surgical thrombectomy and new vena cava clips treatments were promoted to reduce mortality and avoid unexpected complications. Moreover, new strategies have evolved to diagnose this condition. Methodology: PubMed published data was used for articles selection and using the following keys in the mesh ((''DVT''[Mesh])), ((''VTE ''[Mesh])) ((''Deep Venous Thrombosis ''[Mesh])), ((''Venous''[Mesh])). Conclusion: DVT is an annoying and prevalent problem for clinicians and it is important to promote diagnosis and treatment. Although the safety profile of DOACs has been quite favorable, dabigatran and rivaroxaban increase the risk of GI bleeding in patients, and further research is necessary.
Publication Details
Page(s) 76-78
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 11, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
VTE, Heparin, DVT, GI bleeding
References
Galanaud JP,Laroche JP,Righini M. .2013 .The history and historical treatments of deep vein thrombosis. J Thromb Haemost, 10(3) : 402-411.
Stone J,Hangge P,Albadawi H,Wallace A,Shamoun F,Knuttien MG,Naidu S,Oklu R .2017 .Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovascular diagnosis and therapy. 2017 Dec;7(Suppl 3):S276. , 09 : .
Sharif S,Eventov M,Kearon C,Parpia S,Li M,Jiang R,Sneath P,Fuentes CO,Marriott C,de Wit K. . .Comparison of the age-adjusted and clinical probability-adjusted D-dimer to exclude pulmonary embolism in the ED. Am J Emerg Med, 37(5) : 845-850.
Kruger PC,Eikelboom JW,Douketis JD,Hankey GJ .2019 .Deep vein thrombosis: update on diagnosis and management. Med, 10(11) : 50201-524.
Hansen AT,Juul S,Knudsen UB,Hvas AM . .Low risk of venous thromboembolism following early pregnancy loss in pregnancies conceived by IVF. Hum. Reprod. 2018 Oct, 33(10) : 1968-1972.
Barco S,Klok FA,Mahé I,Marchena PJ,Ballaz A,Rubio CM,Adarraga MD,Mastroiacovo D,Konstantinides SV,Monreal M .2018 .Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis. 2019 Jan, 09 : 166-71.
Devis P,Knuttinen MG .2017 .Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management. Cardiovascular diagnosis and therapy. 2017 Dec;7(Suppl 3):S309. , 10 : .
James AH,Jamison MG,Brancazio LR,Myers ER .2005 .Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol, 11(5) : 1311-1315.
Streiff MB,Agnelli G,Connors JM,Crowther M,Eichinger S,Lopes R,McBane RD,Moll S,Ansell J . .Guidance for the treatment of deep vein thrombosis and pulmonary embolism. 2016 Jan, 10(1) : 32-67.
Tran HA,Gibbs H,Merriman E,Curnow JL,Young L,Bennett A,Tan CW,Chunilal SD,Ward CM,Baker R,Nandurkar H R . .New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Medical Journal of Australia, 10(5) : 50004-35.
Parks AL,Kohlwes RJ .2018 .Refining Risk for Deep Vein Thrombosis in Hospitalized Patients. J Gen Intern Med, 10(1) : .
Xing F,Li L,Long Y .2018 .Published 2018 Dec 20. BMC Musculoskelet Disord, 10(1) : 444.
Kraaijpoel N,Carrier M,Le Gal G,McInnes MD,Salameh JP,McGrath TA,van Es N,Moher D,Büller HR,Bossuyt PM,Leeflang MM . .Published 2020 Feb 11. 2020 Feb, 0228788(2) : e0228788.
Wood KE .2008 .A history of pulmonary embolism and deep venous thrombosis. Crit Care Clin, 12(1) : 115-viii.
Behravesh S,Hoang P,Nanda A,Wallace A,Sheth RA,Deipolyi AR,Memic A,Naidu S,Oklu R .2017 .Pathogenesis of thromboembolism and endovascular management. Thrombosis, : .
Weinberg I,Vedantham S,Salter A,Hadley G,Al-Hammadi N,Kearon C,Julian JA,Razavi MK,Gornik HL,Goldhaber SZ,Comerota AJ .2019 .Relationships between the use of pharmacomechanical catheterdirected thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial. Vascular Medicine, 10(5) : 442-51.
López-Núñez JJ,Trujillo-Santos J,Monreal M. . .Management of venous thromboembolism in patients with cancer. J. Thromb. Haemost, 16(12) : 2391-2396.
0

Citations

0

Downloads

9

Views